Syra Health Full Year 2024 Earnings: US$0.50 loss per share (vs US$0.60 loss in FY 2023)

+1.63%

Syra Health Corp. Class A

SYRA

0.31

+1.63%

Syra Health (NASDAQ:SYRA) Full Year 2024 Results

Key Financial Results

Revenue: US$7.98m (up 45% from FY 2023).
Net loss: US$3.76m (loss widened by 28% from FY 2023).
US$0.50 loss per share.

earnings-and-revenue-history — NasdaqCM:SYRA Earnings and Revenue History March 12th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Syra Health shares are down 4.5% from a week ago.

Risk Analysis

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.